Form Bio

The #CGT bottleneck isn’t just biology anymore, it’s proving consistency to regulators. FormManufacturing helps teams optimize constructs, quantify contaminants, detect genomic drift, and generate comparability data for modern IND, CTA, and BLA filings. na2.hubs.ly/H05MRTx0

🎙️ New #Podcast: The Bumpy Road to Breakthroughs: Lessons in #DrugDiscovery with Dr. Len Post. 🎧 Tune in for a candid look at what it really takes to bring breakthrough therapies to life. Listen on Apple: na2.hubs.ly/H06wrrH0 Listen on Spotify: na2.hubs.ly/H06wmrB0

Manufacturing is having its moment in #CGT. The challenge isn’t just scaling production, it’s maintaining genomic continuity. FormManufacturing helps teams optimize constructs upstream and quantify lot-to-lot comparability downstream. Learn More: na2.hubs.ly/H05MQ0Y0

In the 2nd episode of The Algorithm of Life, our CEO Michelle Chen sits down with Dr. Lee Hood, the pioneer of #systemsbiology. "I've always had a lot of faith in the power of big questions to point you in the right direction..." — Dr. Hood 🎙️hubs.li/Q04hx6vC0 #genomics

Announcing FormManufacturing: Design, optimize, & monitor #biomanufacturability for #geneticmedicines. #AI-driven design optimization flags risks early & genomic quality & comparability analytics ensures consistency. hubs.li/Q04g52G20

We’ll be at @Biocom’s #ConvergeSummit April 23, where Michelle Chen, Ph.D., CEO of Form Bio, will be speaking during the lightning talks from 1:30–1:55 PM. Looking forward to connecting!

We’re heading to the 3rd International Human Gene Therapy Conference in Boston (March 23–25). Catch Jeremy Shelley on March 23 at 11:30am: “Optimizing #GeneTherapy Development Through Long-Read Sequencing.” If you’re attending, let’s connect: hubs.li/Q047zht50

In our inaugural #podcast, Michelle Chen, CEO of Form Bio, sits down with Rich Horgan, Founder & CEO of the @CureRareDisease, to share a deeply personal story that became a mission, accelerating #CellandGeneTherapy development for rare diseases. hubs.li/Q045CxPg0

Exciting publication alert! AlphaGenome, published in Nature by Google DeepMind, represents a major milestone in genomic #AI, building on nearly a decade of incremental progress toward unified, sequence-to-function modeling of regulatory biology. hubs.li/Q045q8dG0

Form Bio is headed to Nashville (Feb 19–20) for Frontiers 2026, Phase Capital’s annual summit, where our CEO will join the panel “Beyond the Hype Cycle: Practical Applications of #AI.” We'll explore where AI is delivering real biological insight today. hubs.li/Q040y7hk0

Ensuring #AAV #genomeintegrity is critical for safe, effective therapies. Join us Oct 29, 2PM EDT, as @Catalent_, @form_bio, @Solid_bio & @PacBio discuss how long-read sequencing is transforming rAAV design and development. Register: hubs.li/Q03Nh_-q0 #genetherapy

Proud to announce our partnership with Cure Rare Disease! 🌟 Already: 4.4x boost in AAV yield for a #DMD candidate. Together, we’re accelerating safer, more effective therapies for rare & ultra-rare diseases. accessnewswire.com/newsroom/… #GeneTherapy #RareDisease

🌵🧬 We're headed to @alliancerm #CGMesa25, Oct 6-8! We'd love to connect and share our latest aggregate biological data validating our #AI/ML models : hubs.li/Q03L2Swm0

This week in @BioCentury, a key leadership change lands at the forefront of #genetherapy innovation: Michelle Chen has been named President & CEO of Form Bio, an #AI company advancing #geneticmedicine & #genomeengineering. hubs.li/Q03DC1wX0

🚀 We’re thrilled to welcome Michelle Chen, Ph.D. as Form Bio’s new President & CEO! With 25+ years in AI-driven drug discovery, biotech & pharma—including at @InSilicoMeds—she brings the vision to scale our #AI expertise in #geneticmedicine 👉 hubs.li/Q03D6TXf0

🎉 Big congrats to Brandi Cantarel, PhD, VP of Bioinformatics at @FormBio, for being named one of @DallasInnovates’ Top 75 #AI Innovators in North Texas! 👏 She’s pioneering AI in #genomics to accelerate breakthroughs in human health. 🧬 Read more: hubs.li/Q03ltj0y0

We’re heading to #ASGCT25! Pre-book a meeting with our team or stop by booth #1143 to learn how to improve #AAV #genetherapy development. Join us for in-booth activities featuring our partners Azenta, PacBio and Stanford University. hubs.li/Q03lkL8h0

Form Bio is the tech turning visionary science into reality. From de-extinction to cutting-edge #CGT, our tools design #CRISPR guides at scale, detect off-target edits, & predict functional impact. Let’s talk how we can support your next breakthrough. hubs.li/Q03khCRt0

The woolly mouse is what happens when visionary science meets cutting-edge #AI. At Form Bio, we’re not just powering de-extinction—we’re building tech that’s transforming #geneediting for human health. Learn more. hubs.li/Q03jCLD20